Home

Bullfrog AI Holdings, Inc. - Warrants (BFRGW)

0.5000
-0.1000 (-16.67%)
SummaryNewsPress ReleasesChartHistorical
Previous Close0.6000
Open0.5908
Day's Range0.5000 - 0.6416
52 Week Range0.1499 - 1.100
Volume20,540
Market Cap-
Dividend & YieldN/A (N/A)
1 Month Average Volume24,516

News & Press Releases

BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
GAITHERSBURG, Md., Aug. 26, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a leader in AI-driven drug discovery, announced today that the Company will participate in the H.C. Wainwright 26th Annual Global Investment Conference being held in New York City.
By BullFrog AI Holdings, Inc. · Via GlobeNewswire · August 26, 2024
ASP Isotopes and Bullfrog AI Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / October 27, 2023 / RedChip Companies will air interviews with ASP Isotopes Inc. (NASDAQASPI) and BullFrog AI Holdings, Inc. NASDAQ:BFRGNASDAQBFRG)(NASDAQ:BFRGWNASDAQBFRGW on The RedChip Small Stocks Big Money® Show, a sponsored program on Bloomberg TV, this Saturday, October 28, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
Via ACCESSWIRE · October 27, 2023
Sharps Technology, Inc. and BullFrog AI Holdings, Inc. Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
ORLANDO, FL / ACCESSWIRE / May 19, 2023 / RedChip Companies will air new interviews with Sharps Technology, Inc. (NASDAQ:STSS; STSSW) and BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) on The RedChip Money Report® on Bloomberg TV, this Saturday, May 20, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
Via ACCESSWIRE · May 19, 2023
BullFrog AI Partners with J. Craig Venter Institute to Develop Colorectal Cancer Therapeutic
Collaboration seeks to develop an oncolytic virus that incorporates a novel, precision-targeted approach to improve safety and efficacy
Via ACCESSWIRE · February 23, 2023
Bullfrog AI Announces Closing of $8.4 Million Initial Public Offering
GAITHERSBURG, MD / ACCESSWIRE / February 16, 2023 / BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a digital technology company using machine learning to usher in a new era of precision medicine, announced today the closing of its initial public offering of 1,297,318 units (each, a "Unit," collectively, the "Units") at a price of $6.50 per unit for a total of approximately $8.4 million of gross proceeds to the Company. Each Unit consists of one share of the Company's common stock, one tradeable warrant (each, a "Tradeable Warrant," collectively, the "Tradeable Warrants") to purchase one share of common stock at an exercise price of $7.80 per share, and one non-tradeable warrant (each, a "Non-tradeable Warrant," collectively, the "Non-tradeable Warrants"; together with the Tradeable Warrants, each, a "Warrant," collectively, the "Warrants") to purchase one share of the Company's common stock at an exercise price of $8.125.
Via ACCESSWIRE · February 16, 2023
BullFrog AI to Present at Benzinga All Access Event on Friday, February 17
GAITHERSBURG, MD / ACCESSWIRE / February 15, 2023 / BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a biopharmaceutical company focused on applying its proprietary Artificial Intelligence/Machine Learning platform to improve drug development and shorten clinical trial timelines, today announced that management will present during Benzinga's All Access investor event taking place Friday, February 17, 2023, at 11:00 a.m. ET.
Via ACCESSWIRE · February 15, 2023